Kazakhstan Kagazy appoints Denise Valentine to its board as a non-executive director and chairman of company's remuneration committee; she has more than 20 years of global managerial and investment expertise

ALMATY, Kazakhstan , June 10, 2014 (press release) – Kazakhstan Kagazy PLC (the 'Company') is pleased to announce that Denise Valentine has joined its board as a non-executive director. Denise will chair the Company's Remuneration Committee.

Denise has over 20 years of global managerial and investment experience. She has invested in and managed businesses in the US, India, Africa, Malaysia and Latin America. Her work involves complex multinational transactions and joint ventures.

Ten years ago, Denise founded Terranova Capital, which focuses on providing diverse solutions for clients in emerging markets.

Prior to founding Terra Nova Denise was a portfolio manager at Acumen Fund, where she was responsible for developing and executing an international strategy for healthcare investments.

Denise's managerial experience also includes acting as the CEO of VRex, an advanced imaging hardware and software company, along with running the marketing and technical teams of Biotrace, a diagnostics business which was purchased by 3M. Denise also previously managed external investments and Joint Ventures at Pfizer and worked with Merck in a senior marketing management position.

Denise has a BA from Brown University in Business Economics, and a MS in Biologic Sciences and Biochemistry and MBA from Columbia University.

The Company's CEO, Tomas Mateos Werner, commented: 'I am pleased to welcome Denise to the board, and consider that her financial and managerial experience will well complement the skills of the other board members.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.